Cancer, Gestational Diabetes and Obesity

Additional fat in the body may have destructive impacts, such as producing hormones and development factors can influence the way our cells work. Fat cells can also attract immune cells to body tissues which release chemicals that cause a long-term inflammation. Individuals with obesity have chronic low-level or subacute unresolved inflammations, which is related to expanded malignancy chance.

Gestational diabetes cause problems for your baby and you during pregnancy and after birth. But the risks can be reduced if the condition is detected early and well managed. Gestational diabetes is high blood sugar (glucose) that develops during pregnancy. It happens when your body cannot produce enough insulin – a hormone that helps control blood sugar levels – to meet your extra needs in pregnancy.

  • Genetic Linkage
  • Medication for Diabetes and Cancer
  • Diagnosis
  • Case Studies
  • Obesity and Reproductive Function

Related Conference of Cancer, Gestational Diabetes and Obesity

November 13-14, 2024

33rd International Diabetes and Healthcare Conference

Paris, France
November 18-19, 2024

3rd International Summit on Hormonal Disorders

Madrid, Spain
November 22-23, 2024

20th World Congress on Endocrinology & Diabetes

Amsterdam, Netherlands
November 27-28, 2024

7th Annual Meeting on Diabetes and Endocrinology

Paris, France
November 27-28, 2024

14th World Congress on Endocrinology and Diabetes

Paris, France
February 24-25, 2025

34th European Diabetes Congress

London, UK
March 17-18, 2025

5th European Endocrinology and Diabetes Congress

Paris, France
April 10-11, 2025

5th World Congress on Endocrine and Diabetes

Dubai, UAE
May 19-20, 2025

6th World Summit on Diabetes

Rome, Italy
June 04-05, 2025

4th World Congress on Diabetes and Pediatric Endocrinology

Edinburgh, Scotland

Cancer, Gestational Diabetes and Obesity Conference Speakers

    Recommended Sessions

    Related Journals

    Are you interested in